Editorial Ppublish
PubMed: 40000458 DOI: 10.1007/s00259-025-07160-y
FAP inhibitors: are we really using the best method to evaluate the residence time?
Eur J Nucl Med Mol Imaging 52(9):3062-3065
Authors: Michela Cortesi, Remo Guerrini, Chiara Roccatello, Salvatore Pacifico, Valentina Albanese, Paola Ulivi, Giovanni Paganelli, Sara Bravaccini
Affiliations
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, 44121, Italy.
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
- Department of Medicine and Surgery, University of Enna "Kore", Enna, 94100, Italy.
MeSH
Nuclear Medicine
Cited by
- Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress. EJNMMI Radiopharm Chem, 2025